These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 19505383

  • 1. In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa.
    Tempera G, Mangiafico A, Genovese C, Giudice E, Mastrojeni S, Nicolosi D, Ferneri PM.
    Int J Immunopathol Pharmacol; 2009; 22(2):299-302. PubMed ID: 19505383
    [Abstract] [Full Text] [Related]

  • 2. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials.
    Cantrell HF, Lombardy EE, Duncanson FP, Katz E, Barone JS.
    South Med J; 2004 May; 97(5):465-71. PubMed ID: 15180022
    [Abstract] [Full Text] [Related]

  • 3. Acute otitis externa: an update.
    Schaefer P, Baugh RF.
    Am Fam Physician; 2012 Dec 01; 86(11):1055-61. PubMed ID: 23198673
    [Abstract] [Full Text] [Related]

  • 4. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH.
    Curr Med Res Opin; 2006 Sep 01; 22(9):1725-36. PubMed ID: 16968576
    [Abstract] [Full Text] [Related]

  • 5. Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.
    Dohar JE, Roland P, Wall GM, McLean C, Stroman DW.
    Curr Med Res Opin; 2009 Feb 01; 25(2):287-91. PubMed ID: 19192973
    [Abstract] [Full Text] [Related]

  • 6. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A, Rizwan S, Waycaster C, Wall GM.
    Clin Ther; 2007 Sep 01; 29(9):1950-6. PubMed ID: 18035194
    [Abstract] [Full Text] [Related]

  • 7. Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
    Drehobl M, Guerrero JL, Lacarte PR, Goldstein G, Mata FS, Luber S.
    Curr Med Res Opin; 2008 Dec 01; 24(12):3531-42. PubMed ID: 19032135
    [Abstract] [Full Text] [Related]

  • 8. The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries.
    Pietschmann S, Meyer M, Voget M, Cieslicki M.
    Vet Dermatol; 2013 Aug 01; 24(4):439-45, e96-7. PubMed ID: 23721182
    [Abstract] [Full Text] [Related]

  • 9. Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment.
    Arnes E, Dibb WL.
    Curr Med Res Opin; 1993 Aug 01; 13(3):182-6. PubMed ID: 8222746
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
    Jones RN, Li Q, Kohut B, Biedenbach DJ, Bell J, Turnidge JD.
    Diagn Microbiol Infect Dis; 2006 Jan 01; 54(1):63-71. PubMed ID: 16368476
    [Abstract] [Full Text] [Related]

  • 14. Is transmission electron microscopy (TEM) a promising approach for qualitative and quantitative investigations of polymyxin B and miconazole interactions with cellular and subcellular structures of Staphylococcus pseudintermedius, Escherichia coli, Pseudomonas aeruginosa and Malassezia pachydermatis?
    Voget M, Lorenz D, Lieber-Tenorio E, Hauck R, Meyer M, Cieslicki M.
    Vet Microbiol; 2015 Dec 31; 181(3-4):261-70. PubMed ID: 26527257
    [Abstract] [Full Text] [Related]

  • 15. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa.
    Roland PS, Belcher BP, Bettis R, Makabale RL, Conroy PJ, Wall GM, Dupre S, Potts S, Hogg G, Weber K, Cipro HC Study Group.
    Am J Otolaryngol; 2008 Dec 31; 29(4):255-61. PubMed ID: 18598837
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A study of three preparations in the treatment of otitis externa.
    Slack RW.
    J Laryngol Otol; 1987 Jun 31; 101(6):533-5. PubMed ID: 3036980
    [Abstract] [Full Text] [Related]

  • 18. In vitro interactions of neomycin sulfate, bacitracin, and polymyxin B sulfate.
    Booth JH, Benrimoj SI, Nimmo GR.
    Int J Dermatol; 1994 Jul 31; 33(7):517-20. PubMed ID: 7928043
    [Abstract] [Full Text] [Related]

  • 19. A clinical trial of a topical preparation of miconazole, polymyxin and prednisolone in the treatment of otitis externa in dogs.
    Studdert VP, Hughes KL.
    Aust Vet J; 1991 Jun 31; 68(6):193-5. PubMed ID: 1888310
    [Abstract] [Full Text] [Related]

  • 20. In vitro antimicrobial activity of monensin against common clinical isolates associated with canine otitis externa.
    Chan WY, Hickey EE, Khazandi M, Page SW, Trott DJ, Hill PB.
    Comp Immunol Microbiol Infect Dis; 2018 Apr 31; 57():34-38. PubMed ID: 30017076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.